Congress Adopts New User Fee Program

To fund expanded FDA operations designed to streamline drug development and approval, FDA and industry representatives have negotiated the Prescription Drug User Fee Act III.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-07-02-2002

FDA Proposes Longer National Drug Code

FDA Food Center Reorg Puts Field Inspections in Limbo

Convergence in the Global Regulatory Village